Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb:40:39-40.
doi: 10.1016/j.ebiom.2019.02.008. Epub 2019 Feb 11.

Drug resistance in pancreatic cancer: New player caught in act

Gabriele Capurso  1 , Claudio Sette  2
Affiliations

Drug resistance in pancreatic cancer: New player caught in act

Gabriele Capurso et al. EBioMedicine. 2019 Feb.
No abstract available

PubMed Disclaimer

References

    1. Rahib L., Smith B.D., Aizenberg R., Rosenzweig A.B., Fleshman J.M., Matrisian L.M. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913–2921. - PubMed
    1. Ducreux M., Seufferlein T., Van Laethem J.L., Laurent-Puig P., Smolenschi C., Malka D. Systemic treatment of pancreatic cancer revisited. Semin Oncol. 2018 [pii:S0093-7754(18)30266-5] - PubMed
    1. Ghaneh P., Costello E., Neoptolemos J.P. Biology and management of pancreatic cancer. Gut. 2007;56:1134–1152. - PMC - PubMed
    1. Javed M.A., Beyer G., Le N., Vinci A., Wong H., Palmer D. Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe. Pancreatology. 2019;19:97–104. - PubMed
    1. Reni M., Zanon S., Peretti U., Chiaravalli M., Barone D., Pircher C. Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial. Lancet Gastroenterol Hepatol. 2018;3:691–697. - PubMed

MeSH terms

Substances